Earnings summaries and quarterly performance for RadNet.
Executive leadership at RadNet.
Howard Berger
Detailed
President and Chief Executive Officer
CEO
Cornelis Wesdorp
Detailed
President and Chief Executive Officer - Digital Health
David Katz
Detailed
Executive Vice President, Chief Legal Officer and Corporate Secretary
Gregory Sorensen
Detailed
Executive Vice President, Chief Science Officer
Mark Stolper
Detailed
Executive Vice President and Chief Financial Officer
Michael Murdock
Detailed
Executive Vice President, Mergers and Acquisitions
Mital Patel
Detailed
Executive Vice President of Financial Planning and Analysis and Chief Administrative Officer
Norman Hames
Detailed
President and Chief Operating Officer - Western Operations
Ranjan Jayanathan
Detailed
Executive Vice President, Chief Information Officer
Stephen Forthuber
Detailed
President and Chief Operating Officer - Eastern Operations
Board of directors at RadNet.
Research analysts who have asked questions during RadNet earnings calls.
Brian Tanquilut
Jefferies
7 questions for RDNT
Also covers: ACHC, ADUS, AHCO +29 more
Andrew Mok
Barclays
6 questions for RDNT
Also covers: ACHC, ADUS, AGL +21 more
John Ransom
Raymond James
6 questions for RDNT
Also covers: ACHC, ADUS, ALHC +11 more
David Macdonald
Truist Securities
5 questions for RDNT
Also covers: AVAH, ENSG, GRDN +3 more
Jim Sidoti
Sidoti & Company, LLC
4 questions for RDNT
Also covers: ANIK, GAIA, GOCO +4 more
Yuan Zhi
B. Riley Financial, Inc.
4 questions for RDNT
Also covers: HYPR, LNTH, MIR +4 more
Lawrence Solow
CJS Securities, Inc.
3 questions for RDNT
Also covers: BTSG, CDRE, CLH +13 more
James Sidoti
Sidoti & Company
2 questions for RDNT
Also covers: ANIK, ASRT, GAIA +10 more
Larry Solow
CJS Securities
2 questions for RDNT
Also covers: ARCB, BTSG, CDRE +14 more
Brandon Carney
B. Riley
1 question for RDNT
Also covers: CATX, HYPR, VREX
Evan Kane
Barclays
1 question for RDNT
Grayson McAllister
Truist Securities
1 question for RDNT
Also covers: AVAH, GRDN
Recent press releases and 8-K filings for RDNT.
RadNet Highlights Strong Q3 Performance and Strategic Growth Initiatives at Investor Day
RDNT
Guidance Update
Revenue Acceleration/Inflection
New Projects/Investments
- RadNet reported a record third quarter with 13.4% revenue growth and 15.2% EBITDA growth year-over-year for Q3 2025, leading to increased guidance for both its imaging center business and digital health division.
- The company is strategically transforming into a technology-enabled company, leveraging AI, with its digital health division growing 51.6% in Q3 2025 and projected to achieve 30%+ annual growth.
- RadNet is pursuing aggressive expansion through acquisitions, adding 37 new imaging centers in 2024 and 29 year-to-date in 2025, alongside a strong pipeline of De Novo sites and joint ventures.
- The company anticipates continued double-digit revenue growth of 11-13% (excluding major acquisitions) and margin enhancement, supported by a strong balance sheet with over $800 million in cash and low leverage.
Nov 11, 2025, 2:00 PM
RadNet Reports Record Q3 2025 Results and Raises 2025 Guidance
RDNT
Guidance Update
Revenue Acceleration/Inflection
New Projects/Investments
- RadNet reported record Q3 2025 results, with Total Company quarterly Revenue increasing 13.4% and Digital Health Revenue increasing 51.6% from Q3 2024, leading to a raised 2025 annual guidance for Imaging Center Revenue, Adjusted EBITDA, and Digital Health Revenue.
- The company maintains strong liquidity with an $804.7 million cash balance and an Adjusted EBITDA to Net Debt leverage ratio of approximately 1.0x at quarter end.
- For the 2025-2028 period, RadNet projects a Total Company Revenue CAGR of +11% to +13% and a Digital Health Revenue CAGR of ~30%, with a targeted +100bps to +150bps Adjusted EBITDA margin improvement relative to 2025.
- Key strategic initiatives, including TechLive™ for remote MRI operations, Smart Appointment Management, and the DeepHealth OS, are driving capacity expansion, operational efficiencies, and revenue growth.
Nov 11, 2025, 2:00 PM
RadNet Acquires CIMAR UK to Enhance AI-Powered Imaging Solutions
RDNT
M&A
New Projects/Investments
- RadNet, Inc. (NASDAQ: RDNT) announced the acquisition of CIMAR UK, a leading provider of cloud-native healthcare image management solutions.
- CIMAR will be integrated into DeepHealth, RadNet’s wholly owned subsidiary, to advance connected imaging-based care.
- CIMAR's infrastructure provides data connectivity and interoperability across more than 50% of National Health Service Trusts and 80% of UK private hospital groups.
- The acquisition aims to scale digitally enabled care models across the UK and Europe, leveraging an existing partnership that has shown 76% of lung cancers detected at earlier, more treatable stages in the NHS England’s Lung Cancer Screening Program.
Nov 11, 2025, 11:00 AM
RadNet Acquires Alpha RT's Assets
RDNT
M&A
New Projects/Investments
Product Launch
- RadNet, Inc. acquired the assets of Alpha RT on November 5, 2025, to create a comprehensive remote-imaging portfolio.
- The acquisition combines Alpha RT's staffing services and training programs with DeepHealth's existing FDA-cleared TechLive™ remote scanning technology.
- The expanded remote-imaging portfolio now includes DeepHealth's remote, multi-modality scanning technology, Alpha RT's AI-powered safety monitoring, remote MRI staffing services, comprehensive training, and intelligent resource optimization.
- This strategic move aims to address the challenge of rising patient demand for radiology services and a shortage of imaging technologists.
- DeepHealth's TechLive™ remote scanning technology has demonstrated a 0.06% recall rate on remote scans and a 42% reduction in MRI room closures in pilot studies.
Nov 5, 2025, 11:00 AM
RadNet Discusses Strong Growth, Digital Health, and Expansion Plans
RDNT
Revenue Acceleration/Inflection
New Projects/Investments
Guidance Update
- RadNet, the largest operator of independent freestanding imaging facilities, has achieved a 9.1% compound annual growth rate on its top line since 2007, with recent acceleration driven by a market shift towards lower-cost outpatient centers. The company expects a strong second half of 2025 and beyond, with advanced imaging growing in the mid-single digits and PET/CT growing over 15% on a same-center basis.
- The company is enhancing operational efficiency and margins through its digital health platform, DeepHealth OS, an end-to-end cloud-based operating system automating workflow and diagnostic processes. This platform is being implemented internally first to demonstrate savings before wider licensing.
- RadNet is also investing in clinical AI solutions, such as CMODE, an ultrasound AI technology that has FDA approval for thyroid ultrasound and is expected to seek approval for breast ultrasound in early 2025. This technology is projected to reduce exam times by about a third and increase capacity by 1 to 2 additional scans per machine per day.
- The company is expanding its network and capacity, with 155 of its 405 locations (over 38%) operating as hospital joint ventures, which perform slightly better than wholly-owned centers. RadNet plans to open 11 new de novo centers in 2025 and expects to spend $150 million to $160 million in CapEx this year, supported by over $800 million in cash.
Sep 29, 2025, 6:50 PM
RadNet Reports Record Q2 2025 Revenue and Adjusted EBITDA, Raises Full-Year Guidance
RDNT
Earnings
Guidance Update
M&A
- RadNet achieved record quarterly revenue of $498.2 million, an 8.4% increase year-over-year, and record adjusted EBITDA of $81.2 million, a 12.3% increase year-over-year in Q2 2025.
- The company raised its 2025 full-year guidance for imaging center revenue by $15 million and adjusted EBITDA by $3 million.
- Growth was supported by a focus on advanced imaging, which increased to 27.5% of total procedures, and the implementation of technologies like TechLive, which reduced MRI room closures by 42% in pilot deployments.
- RadNet completed the acquisitions of iCAD on July 17, 2025, and C Mode Technology on June 4, 2025, aiming to expand its digital health offerings and improve operational efficiency. The company also reported a strong cash balance of $833 million and a net debt to adjusted EBITDA ratio of 0.96 as of June 30, 2025, with plans for further investments and de novo facility openings.
Aug 12, 2025, 12:45 PM
RadNet Subsidiary DeepHealth Receives FDA Clearance for TechLive™
RDNT
Product Launch
New Projects/Investments
- DeepHealth, a wholly-owned subsidiary of RadNet, Inc., has received FDA 510(k) clearance for TechLive™, its remote scanning solution.
- TechLive™ is a vendor-agnostic integrated solution that enables remote scanning and centralized operation and supervision of MR, CT, PET/CT, and Ultrasound procedures.
- The solution aims to address radiology technologist shortages, improve operational efficiency, and extend center operating hours.
- In a pilot deployment at 64 RadNet locations in New York, TechLive™ contributed to a 42% decrease in MRI room closure hours during the second quarter of 2025 compared to the same period in 2024.
- More than 300 of RadNet's MR, CT, PET/CT, and Ultrasound systems are currently connected with TechLive™.
Aug 7, 2025, 10:00 AM
RadNet's AI-Powered EBCD Program Added to Southern California Health Plans
RDNT
Product Launch
New Projects/Investments
- RadNet, Inc. announced that Regal Medical Group, Lakeside Community Healthcare, and ADOC Medical Group, affiliates of Heritage Provider Network, will reimburse RadNet for its AI-powered Enhanced Breast Cancer Detection (EBCD) program.
- The EBCD program will be included as a benefit for nearly 600,000 members across Southern California, aiming to increase access to AI-powered breast cancer detection and boost compliance with annual screening guidelines.
- This agreement signifies reimbursement traction for RadNet's EBCD program with commercial payors.
Jul 9, 2025, 10:02 AM
iCAD Acquisition by RadNet Receives Proxy Firm Support
RDNT
M&A
Proxy Vote Outcomes
Takeover Bid
- Leading independent proxy advisory firms Institutional Shareholder Services Inc. (ISS) and Glass, Lewis & Co. have recommended that iCAD, Inc. stockholders vote "FOR" the previously announced all-stock acquisition by RadNet, Inc..
- The Special Meeting of Stockholders to vote on the merger is scheduled for July 14, 2025, at 9:00 a.m. ET.
- iCAD’s Board of Directors also unanimously recommends that stockholders vote "FOR" the merger.
Jul 8, 2025, 12:02 PM
RadNet acquires See-Mode Technologies
RDNT
M&A
- AI in healthcare captured over 50% of digital health funding in Q1, underlining strong investor interest in the sector.
- RadNet, Inc. has acquired See-Mode Technologies, adding FDA-approved AI ultrasound tools for thyroid and breast diagnostics to its portfolio.
- Early deployment of See-Mode’s AI solution has delivered up to a 30% reduction in scan time, boosting operational capacity and potential revenue at RadNet imaging centers.
Jun 17, 2025, 2:17 PM
Quarterly earnings call transcripts for RadNet.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more